Helio Genomics Receives 2024 Innovation Award from California Investment Forum

Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, has been recognized by the California Investment Forum (CIF) for its HelioLiver test for early liver cancer detection. 
 
CIF awarded HelioLiver with the AI-Based Medical Technology award. HelioLiver is a multi-analyte blood test that analyzes cell-free DNA (cfDNA), methylation patterns, serum protein markers and demographic information with a simple blood draw to detect hepatocellular carcinoma, or HCC, the most common form of liver cancer.
 
The 2024 Innovation Awards program recognized groundbreaking companies leading the way in a sustainable, prosperous, and innovative future. The program is sponsored by California State Treasurer Fiona Ma and California State Controller Malia Cohen. 
 
Criteria for the award included:

• Innovation: Helio Genomics has developed advanced early cancer detection technology using AI, particularly their HelioLiver test, which significantly enhances early liver cancer detection.

• Impact: Their technology has the potential to greatly improve diagnostic accuracy and patient outcomes, thereby saving more lives.

• Practicality and Scalability: The blood test method they use is simple, easy to implement, and scalable across various medical settings.

• Market Performance: Helio Genomics has shown excellent market performance, secured multiple funding rounds, and received industry recognition, proving its business model’s sustainability. 

• Academic and Clinical Validation: Their technology has undergone rigorous clinical trials and research validation, ensuring its safety and effectiveness.

• Industry Recognition: Helio Genomics has received several industry awards and recognitions, further proving its leadership in medical technology.

 
CIF fosters international investment and economic development by connecting investors with groundbreaking projects in clean energy, biotechnology, artificial intelligence, and real estate development. Its network includes partnerships with top academic institutions and collaborations with government agencies and major venture capital firms.